Braxia Scientific Corp. (BRAXF)
USD 0.0
(-9.09%)
USD 0.0
(-9.09%)
| Breakdown | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Operating Cash Flow | -7.39 Million | -4.51 Million | -5.05 Million | -288.83 Thousand |
| Net Income | -13.14 Million | -12.13 Million | -88.45 Million | -172.72 Thousand |
| Depreciation & Amortization | 565.88 Thousand | 23.16 Thousand | 19.79 Thousand | 2071.00 |
| Deferred income taxes | -145.88 Thousand | -45.26 Thousand | -3.13 Million | -3.2 Million |
| Stock-based compensation | 859.11 Thousand | 2.42 Million | 3.09 Million | 3.21 Million |
| Change in working capital | -1.29 Million | 149.35 Thousand | 2.36 Million | -123.17 Thousand |
| Other non-cash items | 5.76 Million | 5.06 Million | 81.05 Million | -10.33 Thousand |
| Investing Cash Flow | -1.12 Million | -609 Thousand | -1.3 Million | -60 Thousand |
| Investments in PPE | -902.58 Thousand | -25.21 Thousand | -21.93 Thousand | -60 Thousand |
| Acquisitions | 1786.00 | - | -1.28 Million | - |
| Investment purchases | - | -38.34 Thousand | - | - |
| Sales/Maturities of investments | 11.11 Thousand | - | - | - |
| Other Investing Activities | -238.76 Thousand | -545.44 Thousand | - | - |
| Financing Cash Flow | 1.23 Million | 2.7 Million | 14.41 Million | 1.2 Million |
| Debt repayment | -27.8 Thousand | -11.38 Thousand | -60 Thousand | - |
| Dividends payments | - | - | - | - |
| Common Stock Repurchased | - | - | - | - |
| Common Stock Issuance | 1.26 Million | 2.71 Million | 14.37 Million | 1.2 Million |
| Other Financing Activities | 1.23 Million | 2.7 Million | 97.72 Thousand | 5.28 Million |
| Accounts receivables | - | - | - | - |
| Accounts payables | - | - | - | 53.26 Thousand |
| Inventory | - | - | - | -33.78 Thousand |
| Other working capital | -1.29 Million | 149.35 Thousand | 2.36 Million | -142.65 Thousand |
| Cash at beginning of period | 8.67 Million | 11.1 Million | 855.66 Thousand | - |
| Cash at end of period | 1.46 Million | 8.67 Million | 11.1 Million | 855.66 Thousand |
| Capital Expenditure | -902.58 Thousand | -25.21 Thousand | -21.93 Thousand | -60 Thousand |
| Effect of forex changes on cash | 75.76 Thousand | - | 3.05 Million | - |
| Net cash flow / Change in cash | -7.21 Million | -2.42 Million | 10.24 Million | 855.66 Thousand |
| Free Cash Flow | -8.3 Million | -4.54 Million | -5.07 Million | -348.83 Thousand |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -907.04 Thousand | -272.83 Thousand | -802.25 Thousand | -7.65 Million | -13.14 Million | -2.17 Million |
| Depreciation & Amortization | 73.83 Thousand | 73.34 Thousand | 56.21 Thousand | 162.02 Thousand | 565.88 Thousand | 189.92 Thousand |
| Deferred income taxes | -150.87 Thousand | -153.05 Thousand | -120.37 Thousand | -145.88 Thousand | -145.88 Thousand | -529.09 Thousand |
| Stock-based compensation | 3206.00 | 6358.00 | 7950.00 | 110.58 Thousand | 859.11 Thousand | 149.24 Thousand |
| Change in working capital | 259.84 Thousand | -4752.00 | 164.94 Thousand | 730.02 Thousand | -1.29 Million | -1.54 Million |
| Other non-cash items | 188.47 Thousand | 209.41 Thousand | 128.35 Thousand | 5.48 Million | 5.76 Million | 215.95 Thousand |
| Investing Cash Flow | -9112.00 | 27 Thousand | -15.09 Thousand | -18.44 Thousand | -1.12 Million | 52.32 Thousand |
| Investments in PPE | -9112.00 | - | -1580.00 | -31.95 Thousand | -902.58 Thousand | 52.32 Thousand |
| Acquisitions | - | - | - | -13.51 Thousand | 1786.00 | - |
| Investment purchases | - | - | -13.51 Thousand | 2396.00 | - | - |
| Sales/Maturities of investments | - | - | - | 11.11 Thousand | 11.11 Thousand | - |
| Other Investing Activities | - | 27 Thousand | -13.51 Thousand | 13.51 Thousand | -238.76 Thousand | 99.97 Thousand |
| Financing Cash Flow | -42.5 Thousand | -7887.00 | -14.18 Thousand | 1.25 Million | 1.23 Million | -6264.00 |
| Debt repayment | -42.5 Thousand | -7887.00 | -14.18 Thousand | -8953.00 | -27.8 Thousand | -6264.00 |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | 1.26 Million | 1.26 Million | - |
| Other Financing Activities | - | - | -14.18 Thousand | 1.25 Million | 1.23 Million | -6264.00 |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 259.84 Thousand | -4752.00 | 164.94 Thousand | 730.02 Thousand | -1.29 Million | -1.54 Million |
| Cash at beginning of period | 709.68 Thousand | 861.39 Thousand | 1.46 Million | 1.49 Million | 8.67 Million | 5.17 Million |
| Cash at end of period | 128.34 Thousand | 709.68 Thousand | 861.39 Thousand | 1.46 Million | 1.46 Million | 1.49 Million |
| Capital Expenditure | -9112.00 | - | -1580.00 | -31.95 Thousand | -902.58 Thousand | 52.32 Thousand |
| Effect of forex changes on cash | 2840.00 | -2306.00 | -6481.00 | 50.35 Thousand | 75.76 Thousand | -44.23 Thousand |
| Net cash flow / Change in cash | -581.33 Thousand | -151.71 Thousand | -600.91 Thousand | -30.28 Thousand | -7.21 Million | -3.68 Million |
| Free Cash Flow | -541.67 Thousand | -141.51 Thousand | -566.74 Thousand | -1.34 Million | -8.3 Million | -3.63 Million |
3305
KERALAYUR
CIO-PA
TGTMF
AKCCF
RCOI